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A 40-year-old female presented with the chief complaints of fever for 3 months and intermittent pain in abdomen for 2 months. On examination, the patient was middle-aged female with average built. Clinically, the patient had pallor, icterus, edema feet, and ascites. Pulse rate was 100/min and blood pressure was 110/80 mmHg. Chest and cardiovascular system examination was normal. Per abdomen examination was soft, tenderness was present in the right hypochondrium, and globular mass was palpable in the right hypochondrium. Per rectum examination was normal. Laboratory investigation was suggestive of low hemoglobin (8.4 g/dl), raised total (17.87 mg/dl) and direct bilirubin (14.9 mg/dl), raised alkaline phosphatase (896.3 IU/L), and decreased albumin (2.45 mg/ dl). Ultrasound abdomen showed a mass in gallbladder fossa with liver metastasis with dilatation of intrahepatic biliary radicles (IHBR). In view of this presentation, percutaneous transhepatic biliary drainage (PTBD) was done for making a conduit for bile. Biopsy from gallbladder fossa mass was suggestive of SCC [ Figure 1 ]. In view of locally advanced features and deranged bilirubin, after PTBD, single-agent gemcitabine was given to the patient. At present, the patient is still undergoing chemotherapy at our center and is doing well. At present, total bilirubin had come down to 2.6 mg/dl with direct fraction being 1.98 mg/dl. Furthermore, international normalized ratio had decreased to 1.5 mg/ dl. Being inoperable, the patient was given single-agent gemcitabine. After receiving two cycles of chemotherapy, bilirubin had declined and the appetite and performance status had improved. After three cycles of chemotherapy, we planned to evaluate the patient to analyze the response to chemotherapy.
Primary carcinoma of gallbladder includes various histologies from adenocarcinoma, adenosquamous carcinoma, SCC, and oat cell carcinoma in decreasing order of incidence.
SCC of gallbladder is a rare malignant with incidence ranging from 0% to 12.7%. Source of this epithelium in SCC of gallbladder is questionable; however, multiple theories have been put forth to explain the origin with most plausible theory being squamous metaplasia or squamous differentiation of adenocarcinoma.
The explanation being given to hypothesize its origin is that the squamous cells originate from preexisting metaplastic squamous epithelium which is the most accepted theory with others being that the SCC of the gallbladder originates from squamous differentiation of the adenocarcinoma cells, through expression of mixed phenotypes within a single tumor. [2] [3] [4] Major risk factor as for any type of gallbladder carcinoma is gallstone, with 90% of squamous cell variant having cholelithiasis. The most common symptom is pain, which occurs in 66% of patients, rest being the right hypochondrial mass or jaundice.
Radical resection forms the mainstay of treatment for patients with locally invasive SCC and offers the only chance for cure. In relapsed or metastatic setting, various chemotherapy regimens have been used such as GEMOX (gemcitabine + oxaliplatin), FOLFOX (5 fluorouracil + oxaliplatin), FOLFIRI (5 fluorouracil + irinotecan), and cisplatin + gemcitabine. Of these regimens, cisplatin + gemcitabine had shown efficacy in this setting.
In our case, the patient had metastatic disease at presentation with dilated IHBR which is rare [5] and the treatment strategy has been not still elucidated and is based on the isolated case reports being published, so this case has been presented as an attempt to throw some light over this uncommon histology which makes clinicians perplexed in devising the treatment plan.
Pure primary SCC of the gallbladder is rarely reported. Clinicians and pathologists must be aware of its florid presentation.
Financial support and sponsorship
Nil.
Letters to Editor

Figure 1: Keratin pearls and squamous cell carcinoma cells involving the gallbladder (H and E, ×40)
Pacemaker lead infective endocarditis in immunocompetent host due to Aspergillus: An uncommon occurrence
Editor, Aspergillus infections of pacemaker leads are extremely uncommon. The most cases reported are characterized by an aggressive behavior in immunocompromised patients with high mortality. [1] Many risk factors have been associated with the invasive aspergillosis, including diabetes mellitus, transplantation, leukopenia, drug therapy like use of corticosteroids and immunosuppressive. [2] We report the first case to our knowledge about rare occurrence of pacemaker lead infection in an immunocompetent host.
A known hypertensive 50-year-old patient had undergone permanent pacemaker implantation in 2011 due to syncope and trifascicular block. At that time, an implantable high impedance permanent pacing lead was inserted in right ventricular apex through right subclavian vein and thus single chamber multiprogrammable pacemaker was installed. Right atrial pole was placed in right atria, and pulse generator was placed in the right infraclavicular fossa. Now he presented in March 2015 with fever and breathlessness of 2 weeks duration. Two-dimensional echocardiography showed concentric left ventricular hypertrophy with some mobile structure seen in right atrium attached to pacing lead? vegetation. Moderate tricuspid regurgitation (TR) was noted with pulmonary artery systolic pressure (PASP) of 35 mmHg. Ejection fraction was 60%. Three-dimensional transesophageal echocardiography was done which showed large round-shaped multiple mobile masses of size 4.5 cm × 6.5 cm attached to pacing lead and oscillating across tricuspid valve; echo density was comparable to the endocardium. At superior vena cava, level small echogenic masses were also noted. PASP was 40 mm of Hg. Thus, the diagnosis of infective endocarditis with TR and pacing lead vegetation was made. Ultrasound showed mild bilateral pleural effusion with fatty liver and increased echogenicity of both kidneys with diminished corticomedullary differentiation. His viral markers were nonreactive. Serum procalcitonin levels were 11.86 ng/ml indicating severe sepsis. Aspergillus galactomannan antigen value was 4.09-significantly positive (<0.5 = negative) suggesting invasive fungal infection. Total leukocyte count was 16.8 × 10 9 /L with neutrophilia and eosinophilia. Hemoglobin was 9.8 g/dl, platelet count: 295 × 10 3 /ul, Partial Thromboplastin Time Activated with Kaolin (PTTK): 37.8 s, urea: 333 mg/dl, creatinine: 7.19 followed by 5.72 mg/dl after a day. He was not a known diabetic with HbA1C levels were 6.2%. Liver and renal function tests (LFTs & RFTs) were in normal range. Urine and blood culture showed no growth of any pyogenic organisms. Suction tip on Gram-staining show no Gram-positive organisms, but culture showed the presence of Escherichia coli showing sensitivity to amikacin. Bilateral lower limb venous Doppler was normal. Malaria antigen, leptospira IgM, and H1N1 were negative. His fever was persisting near to 100°F. Underwent hemodialysis because of
